These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17143171)

  • 41. The role of sympathetic activation in cardiovascular disease.
    Cohen JD; Egan BM
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):4-10. PubMed ID: 19667664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reflex hypertension--cardiogenic hypertensive chemoreflex].
    Imamura K; Hayashi T; James TN
    Ryoikibetsu Shokogun Shirizu; 1996; (12):155-8. PubMed ID: 9047431
    [No Abstract]   [Full Text] [Related]  

  • 43. [Disturbed cardiovascular reflex--a cause of primary arterial hypertension?].
    Koshev VI; Petrov ES; Volobuev AN; Kondurtsev VA
    Klin Med (Mosk); 2010; 88(3):74-6. PubMed ID: 20608072
    [No Abstract]   [Full Text] [Related]  

  • 44. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
    Moretti JL; Burke SL; Evans RG; Lambert GW; Head GA
    J Hypertens; 2009 Sep; 27(9):1838-48. PubMed ID: 19512943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.
    Zilch O; Vos PF; Oey PL; Cramer MJ; Ligtenberg G; Koomans HA; Blankestijn PJ
    J Hypertens; 2007 Jun; 25(6):1285-9. PubMed ID: 17563543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sympathetic overactivity in dialysis patients-Underappreciated and clinically consequential.
    Hoye NA; Wilson LC; Jardine DL; Walker RJ
    Semin Dial; 2019 May; 32(3):255-265. PubMed ID: 30461070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance.
    Blankestijn PJ; Ligtenberg G; Klein IH; Koomans HA
    Nephrol Dial Transplant; 2000 Jun; 15(6):755-8. PubMed ID: 10831622
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypertension and the failing kidney.
    Toto RD
    Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):165-6. PubMed ID: 11224689
    [No Abstract]   [Full Text] [Related]  

  • 49. Beta-blockade in chronic dialysis patients.
    Furgeson SB; Chonchol M
    Semin Dial; 2008; 21(1):43-8. PubMed ID: 18251957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
    Penne EL; Neumann J; Klein IH; Oey PL; Bots ML; Blankestijn PJ
    J Nephrol; 2009; 22(2):208-15. PubMed ID: 19384838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regulation of blood pressure in dialyzed patients].
    Kes P; Basić-Jukić N; Jurić I; Brunetta B
    Lijec Vjesn; 2006; 128(11-12):368-73. PubMed ID: 17212199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal neural activity in hepatorenal syndrome.
    DiBona GF
    Kidney Int; 1984 May; 25(5):841-53. PubMed ID: 6471670
    [No Abstract]   [Full Text] [Related]  

  • 53. Essential hypertension and the sympathetic nervous system.
    Grassi G; Quarti-Trevano F; Dell'oro R; Mancia G
    Neurol Sci; 2008 May; 29 Suppl 1():S33-6. PubMed ID: 18545892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemodynamics and pathogenesis of arterial hypertension in chronic renal insufficiency].
    Agrest A; Finkielman S; Irigoyen H
    Medicina (B Aires); 1973; 33(5):511-21. PubMed ID: 4779611
    [No Abstract]   [Full Text] [Related]  

  • 56. Oxidative stress contributes to renovascular hypertension.
    Oliveira-Sales EB; Dugaich AP; Carillo BA; Abreu NP; Boim MA; Martins PJ; D'Almeida V; Dolnikoff MS; Bergamaschi CT; Campos RR
    Am J Hypertens; 2008 Jan; 21(1):98-104. PubMed ID: 18091751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure.
    Hansen J; Victor RG
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):636-43. PubMed ID: 7881990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sympathetic activation in chronic kidney disease: out of the shadow.
    Schlaich MP
    Hypertension; 2011 Apr; 57(4):683-5. PubMed ID: 21300664
    [No Abstract]   [Full Text] [Related]  

  • 59. Sympathetic hyperactivity--a hidden enemy in chronic kidney disease patients.
    Blankestijn PJ
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S293-7. PubMed ID: 17556322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac neural discharge preceding sudden death: efferent, afferent or both?
    Elam M
    Clin Auton Res; 2003 Oct; 13(5):314-5. PubMed ID: 14564652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.